
Cancer News
Gravitas: FDA approves life-changing therapy for Diabetes
| November 21, 2022
The FDA has accepted a life-altering treatment for Diabetes. It claims an antibody called Teplizumab can postpone the start of Type 1 Diabetes. Priyanka Sharma reports. #Gravitas #FDA
Read More
